Welcome to our dedicated page for Orion S.A. news (Ticker: $OEC), a resource for investors and traders seeking the latest updates and insights on Orion S.A. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Orion S.A.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Orion S.A.'s position in the market.
Orion S.A. reported financial results for the first quarter of 2024 with net sales of $502.9 million, up $2.2 million year over year, and net income of $26.7 million, down $15.6 million. Diluted EPS was $0.45, down $0.25 year over year. Adjusted EBITDA was $85.3 million, down 16% year over year. Despite the decrease in income and EPS compared to the previous year, the company's CEO highlighted positive indicators such as increased gross profit margins and strong volumes in key markets. Orion expects growth in 2024 with progress towards financial goals.
